Pan-cancer analysis revealed that Centromere Protein A (CENPA) and Metallopeptidase Inhibitor 1 (TIMP1) were highly expressed in most cancers and significantly associated with a poorer prognosis, also in ccRCC. Here, CENPA is linked to nonpapillary renal cell carcinoma.